US Stock MarketDetailed Quotes

ENSC Ensysce Biosciences

Watchlist

0.2235
-0.0086-3.71%

Close Oct 4 16:00 ET

0.2331
+0.0096+4.30%

Post 20:01 ET

2.53MMarket Cap-82P/E (TTM)

Ensysce Biosciences Stock Forum

Clintzilla

Oct 1 05:35

$Ensysce Biosciences (ENSC.US)$ RS, something huge looming before Phase 3? or Buyout coming if they stole all the shares.. gambling is good until it's not or not until it's good..

joeyboulevard

Sep 30 06:01

$Ensysce Biosciences (ENSC.US)$ after the offering, this company has not been capable of maintaining compliance. bad sign. a split is near .... or delisting.

joeyboulevard

Sep 25 11:33

$Ensysce Biosciences (ENSC.US)$ lowest I've ever seen.

Jaguar8

Sep 19 07:15

NEWS

$Ensysce Biosciences (ENSC.US)$
Ensysce Biosciences Submits Phase 3 Protocol to the FDA
Ensysce Biosciences (NASDAQ:ENSC) has submitted its Phase 3 protocol to the FDA for PF614, a novel opioid designed to treat moderate to severe post-surgical pain. The study, PF614-301, will evaluate the efficacy and safety of PF614 compared to placebo and an active comparator in patients undergoing abdominoplasty. Key features of PF614 include:
1. Longer-lasting pain relief (twice the duration of OxyContin...